Urology · Saginaw, MI
NPI
1013900190
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1117 S Washington Ave
Saginaw, MI, 48601
Phone (989) 791-4020
Groups this clinician bills Medicare through
Medicare paid, 2024
$803K
17,453 services
Medicare patients, 2024
1,771
Average age 75
Drug cost, 2024
$3.0M
13,839 prescriptions
Company payments, 2025
$1,637
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Glenn E Kershen was code J1952 (leuprolide injectable, camcevi, 1 mg), 3,486 times for 54 patients. In total Glenn E Kershen billed 17,453 services in 83 codes, and Medicare paid $803K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 3,486 | 54 | $45.21 | $158K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,822 | 1,379 | $11.52 | $21K |
| 51798 Ultrasound - Nonspecific | Office | 1,119 | 887 | $7.17 | $8,025 |
| 99213 Office E&M - Established | Office | 1,029 | 836 | $58.57 | $60K |
| 99214 Office E&M - Established | Office | 1,002 | 810 | $82.16 | $82K |
| 81002 Clinical Chemistry | Office | 914 | 761 | $3.37 | $3,080 |
| 82570 Clinical Chemistry | Office | 762 | 638 | $5.02 | $3,826 |
| 52000 Cystourethroscopy | Office | 370 | 312 | $159.79 | $59K |
| 99204 Office E&M - New | Office | 242 | 242 | $104.47 | $25K |
| 99221 Hospital E&M - Initial | Facility | 158 | 149 | $62.07 | $9,808 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 136 | 19 | $139.03 | $19K |
| 99231 Hospital E&M - Subsequent | Facility | 115 | 62 | $37.73 | $4,339 |
| 96402 Chemotherapy Administration | Office | 106 | 63 | $22.79 | $2,416 |
| 52442 Cystourethroscopy | Office | 94 | 16 | $609.56 | $57K |
| 99203 Office E&M - New | Office | 84 | 84 | $68.97 | $5,794 |
By year: 2022 $600K for 11,920 services; 2023 $701K for 14,416 services; 2024 $803K for 17,453 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 914 | 761 | $3.37 | $3,080 |
| 82570 Clinical Chemistry | 762 | 638 | $5.02 | $3,826 |
Medicare prescription drug claims, 2024
In 2024, the drug Glenn E Kershen prescribed most often to Medicare patients was Tamsulosin Hcl, with 4,201 prescriptions and refills. In total Glenn E Kershen wrote 13,839 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 4,201 | 11,668 | 1,383 | $123K |
| Finasteride Generic | 1,697 | 4,673 | 527 | $34K |
| Ciprofloxacin Hcl Generic | 1,011 | 1,011 | 771 | $4,120 |
| Cephalexin Generic | 831 | 1,386 | 520 | $7,485 |
| Solifenacin Succinate Generic | 795 | 2,086 | 321 | $40K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 480 | 932 | 208 | $18K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 432 | 1,241 | 145 | $16K |
| Myrbetriq Mirabegron | 414 | 872 | 150 | $375K |
| Gemtesa Vibegron | 410 | 836 | 134 | $378K |
| Cefdinir Generic | 340 | 342 | 254 | $4,527 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 314 | 731 | 101 | $8,693 |
| Trimethoprim Generic | 220 | 579 | 79 | $21K |
| Silodosin Generic | 204 | 562 | 78 | $22K |
| Levofloxacin Generic | 200 | 200 | 175 | $702 |
| Estradiol Generic | 161 | 372 | 80 | $8,565 |
Brand drugs: - claims; generic drugs: 12,558 claims; opioid claims: 98.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Glenn E Kershen $1,637 ($1,637 in general payments such as food, travel and fees) from 24 companies. The largest payer was Janssen Biotech, Inc. with $270.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 9 | $270 |
| Astellas Pharma US Inc 4503.T | 5 | $170 |
| Pfizer Inc. PFE | 8 | $159 |
| Teleflex LLC TFX | 9 | $148 |
| Sumitomo Pharma America, Inc. 4506.T | 6 | $119 |
| Dendreon Pharmaceuticals LLC | 3 | $108 |
| Ferring Pharmaceuticals Inc. | 3 | $68.01 |
| Medtronic, Inc. MDT | 2 | $61.95 |
| Merck Sharp & Dohme LLC MRK | 2 | $61.85 |
| Coloplast Corp | 3 | $54.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.